Thank you for purchasing
CHA’s 2020 Consent Manual (Individual PDF version).
Limited Use License (Printable copy): In purchasing this electronic publication (Publication), the individual who purchased it (Purchaser) agrees to abide by the terms of this Limited Use License. This Limited Use License:
Gives Purchaser a non-exclusive, non-assignable, royalty free, perpetual, limited right to use this electronic publication only for his/her personal use; and
Prohibits Purchaser from posting, reproducing, distributing, disseminating, transmitting, or otherwise allowing anyone else to access or use this Publication. CHA is and will be the sole and exclusive owner of all right, title, and interest, including intellectual property rights, in this Publication and its contents. CHA will strictly enforce the terms of this Limited Use License.
Note: Print functionality is disabled in the Individual PDF. If you are interested in posting a PDF to an Intranet please contact Bob Mion at 916-552-7508 or email@example.com.
Purchases that include electronic publications are not refundable. For questions about the policy, or retrieving the manual, contact Publications.
To access the PDF, submit form below.
The Centers for Medicare & Medicaid Services (CMS) has issued the proposed rule for the inpatient rehabilitation facility prospective payment system (IRF PPS) for federal fiscal year (FFY) 2020. If finalized, the provisions would be effective Oct. 1, 2020.
Last Friday, the Department of Health Care Services (DHCS) released state fiscal year (SFY) 2017-18 Phase 2 encounter volume charts for the Hospital Fee Program to all health plans and hospitals. The data cover Jan. 1 – June 30, 2018, and are available via the secure file transfer protocol site.
Earlier this month, the Department of Health Care Services (DHCS) collected from hospitals the fees associated with the Cycle 9 fee-for-service (FFS) payments. As previously shared, hospitals will receive the corresponding FFS payment on April 22.
The government and academic medical centers need to rethink their technology transfer policies, which have allowed the price of specialty drugs to soar to unsustainable heights.
The latest targeted therapies for cancer and genetic diseases are coming to market with price tags approaching a half-million dollars per patient. What most have in common are their origins in academic or government labs funded by the National Institutes of Health.
In response to requests from CHA and other stakeholders, the U.S. Department of Health and Human Services (HHS) has extended the comment period for its two proposed rules on interoperability and information blocking to June 3.
Yesterday, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for the federal fiscal year (FFY) 2020 inpatient psychiatric facility (IPF) prospective payment system (PPS).
Please find materials for the April 19 CHA member forum on the interoperability proposed rules issued by the Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC).